(ACKB) Ackermans & Van Haaren - Ratings and Ratios

Exchange: BR • Country: Belgium • Currency: EUR • Type: Common Stock • ISIN: BE0003764785

ACKB: Dredging, Offshore Services, Private Banking, Real Estate, Energy Resources, Growth Capital

Ackermans & Van Haaren NV (ACKB) is a diversified Belgian holding company with a broad portfolio of businesses spanning marine engineering, private banking, real estate, senior care, energy, and growth capital. The company operates through six primary segments: Marine Engineering & Contracting, Private Banking, Real Estate & Senior Care, Energy & Resources, and AvH & Growth Capital. Its Marine Engineering & Contracting division specializes in dredging, offshore renewable energy projects, and port infrastructure development. The Private Banking segment offers wealth management and specialized financial services to high-net-worth individuals and entrepreneurs. The Real Estate & Senior Care division focuses on mixed-use property development and senior living facilities. The Energy & Resources segment includes crude palm oil production, banana plantations, and cement manufacturing. The AvH & Growth Capital division encompasses a wide range of activities, including process automation, biogas production, specialty chemicals, media solutions, logistics, and life sciences. The company, founded in 1876, is headquartered in Antwerp, Belgium.

Based on the technical and fundamental data, the 3-month outlook for Ackermans & Van Haaren NV (ACKB) indicates potential sideways trading with a bullish bias. The stock is currently trading above its SMA 20 (198.13), SMA 50 (197.71), and SMA 200 (187.58), signaling positive momentum. The ATR of 4.85 suggests moderate volatility. With a P/E ratio of 13.61 and a forward P/E of 13.44, the stock is fairly valued relative to its earnings. The RoE of 11.36% reflects decent profitability. Expect the stock to consolidate near its current level of 209.60, with potential breakout points at 215 and 220. Support levels are likely at 200 and 195. The market cap of 6245.66M EUR and P/S ratio of 1.03 suggest a stable valuation. Investors should monitor earnings growth and sector performance for further direction.

Additional Sources for ACKB Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ACKB Stock Overview

Market Cap in USD 7,089m
Sector Industrials
Industry Engineering & Construction
GiC Sub-Industry Multi-Sector Holdings
IPO / Inception

ACKB Stock Ratings

Growth Rating 76.2
Fundamental 53.7
Dividend Rating 61.3
Rel. Strength 14.4
Analysts -
Fair Price Momentum 230.37 EUR
Fair Price DCF 411.78 EUR

ACKB Dividends

Dividend Yield 12m 1.71%
Yield on Cost 5y 3.15%
Annual Growth 5y 7.94%
Payout Consistency 99.4%

ACKB Growth Ratios

Growth Correlation 3m 60.8%
Growth Correlation 12m 89%
Growth Correlation 5y 84.8%
CAGR 5y 14.03%
CAGR/Max DD 5y 0.52
Sharpe Ratio 12m 1.86
Alpha 25.46
Beta 0.356
Volatility 18.37%
Current Volume 27.8k
Average Volume 20d 28.4k
What is the price of ACKB stocks?
As of April 26, 2025, the stock is trading at EUR 211.00 with a total of 27,766 shares traded.
Over the past week, the price has changed by +3.53%, over one month by +1.83%, over three months by +14.49% and over the past year by +36.43%.
Is Ackermans & Van Haaren a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ackermans & Van Haaren (BR:ACKB) is currently (April 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.66 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACKB as of April 2025 is 230.37. This means that ACKB is currently overvalued and has a potential downside of 9.18%.
Is ACKB a buy, sell or hold?
Ackermans & Van Haaren has no consensus analysts rating.
What are the forecast for ACKB stock price target?
According to ValueRays Forecast Model, ACKB Ackermans & Van Haaren will be worth about 248.8 in April 2026. The stock is currently trading at 211.00. This means that the stock has a potential upside of +17.91%.
Issuer Forecast Upside
Wallstreet Target Price 226.2 7.2%
Analysts Target Price - -
ValueRay Target Price 248.8 17.9%